Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 2/20 | 0.43 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70900 | 0.86 | STAT3 (0.46) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL140992 | 0.86 | STAT3 (0.46) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL1730532 | 0.86 | STAT3 (0.46) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL70901 | 0.86 | STAT3 (0.46) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL3508141 | 0.84 | STAT3 (0.44) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL3508146 | 0.84 | STAT3 (0.44) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL3317915 | 0.84 | STAT3 (0.44) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL15189067 | 0.83 | STAT3 (0.43) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL8172920 | 0.83 | STAT3 (0.43) | STAT3DHODHGAACYP2D6ALDH1A1 | |
| SCHEMBL8173710 | 0.83 | STAT3 (0.43) | STAT3DHODHGAACYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7777033-B2 | Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2010-08-17 | — | — | US | claimed |
| US-20080188655-A1 | Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof | MICRO SCIENCE TECH CO., LTD. (KR) | 2008-08-07 | — | — | US | claimed |
| WO-2018167269-A1 | COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER | Argonaut Therapeutics Limited (GB) | 2018-09-20 | — | — | WO | disclosed |
| US-8703289-B2 | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same | JSR CORPORATION (JP) | 2014-04-22 | — | — | US | disclosed |
| EP-1837656-B1 | Magnetic particles and method for producing the same | JSR CORP (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-7713627-B2 | Magnetic particles comprising an organic polymer layer and method for producing the same | JSR CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| EP-1890147-B1 | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same | JSR CORP (JP) | 2010-01-27 | — | — | EP | disclosed |
| EP-1780544-B1 | Magnetic particles for diagnostics | JSR CORP (JP) | 2009-12-09 | — | — | EP | disclosed |
| EP-1890147-A1 | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same | JSR Corporation (JP) | 2008-02-20 | — | — | EP | disclosed |
| EP-1890148-A1 | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same | JSR Corporation (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-20070224424-A1 | MAGNETIC PARTICLES AND METHOD FOR PRODUCING THE SAME | JSR CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1837656-A1 | Magnetic particles and method for producing the same | JSR Corporation (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070099814-A1 | Organic polymer particles and process for producing the same, magnetic particles for diagnostics, carboxyl group-containing particles and process for producing the same, and probe-bound particles and process for producing the same | JSR CORPORATION (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1780544-A1 | Magnetic particles for diagnostics | JSR Corporation (JP) | 2007-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188655-A1 | Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof | PCNA, HSF1, TERB1 | STAT3 4383/4885DHODH 2130/4885GAA 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.